Search research articles
Contact Us
Filters
Showing results (171-180 of 260) with videos related to
Page
of 26
Sort By:
Heart Rhythm
|
July 3, 2013
Malignant arrhythmogenic right ventricular dysplasia/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity
Anneline S J M te Riele, Cynthia A James, Aditya Bhonsale, et al.
Cardiovascular Drugs and Therapy
|
February 17, 2020
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
American Journal of Human Genetics
|
February 2, 2024
Using implementation science to evaluate a population-wide genomic screening program: Findings from the first 20,000 In Our DNA SC participants
Caitlin G Allen, Kelly J Hunt, Lori L McMahon, et al.
European Journal of Heart Failure
|
March 2, 2026
Impact of acoramidis on clinical stability in transthyretin amyloid cardiomyopathy: Observations from ATTRibute-CM
Francesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia, et al.
Circulation. Cardiovascular Genetics
|
December 25, 2009
Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy
A Dénise den Haan, Boon Yew Tan, Michelle N Zikusoka, et al.
Circulation. Heart Failure
|
October 28, 2024
Effect of Acoramidis on Myocardial Structure and Function in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Cardiac Magnetic Resonance (CMR) Substudy
Yousuf Razvi, Daniel P Judge, Ana Martinez-Naharro, et al.
Cardiovascular Drugs and Therapy
|
June 18, 2020
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Nature Medicine
|
January 24, 2007
Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states
Ronald D Cohn, Christel van Erp, Jennifer P Habashi, et al.
Journal of Cardiovascular Development and Disease
|
January 29, 2016
Targeted <i>Mybpc3</i> Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities
Daniel P Judge, Hany Neamatalla, Russell A Norris, et al.
Journal of Personalized Medicine
|
August 26, 2022
Lessons Learned from the Pilot Phase of a Population-Wide Genomic Screening Program: Building the Base to Reach a Diverse Cohort of 100,000 Participants
Caitlin G Allen, Leslie Lenert, Kelly Hunt, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 260) with videos related to
Sort By:
Page
of 26
Heart Rhythm
|
July 3, 2013
Malignant arrhythmogenic right ventricular dysplasia/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity
Anneline S J M te Riele, Cynthia A James, Aditya Bhonsale, et al.
Cardiovascular Drugs and Therapy
|
February 17, 2020
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
American Journal of Human Genetics
|
February 2, 2024
Using implementation science to evaluate a population-wide genomic screening program: Findings from the first 20,000 In Our DNA SC participants
Caitlin G Allen, Kelly J Hunt, Lori L McMahon, et al.
European Journal of Heart Failure
|
March 2, 2026
Impact of acoramidis on clinical stability in transthyretin amyloid cardiomyopathy: Observations from ATTRibute-CM
Francesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia, et al.
Circulation. Cardiovascular Genetics
|
December 25, 2009
Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy
A Dénise den Haan, Boon Yew Tan, Michelle N Zikusoka, et al.
Circulation. Heart Failure
|
October 28, 2024
Effect of Acoramidis on Myocardial Structure and Function in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Cardiac Magnetic Resonance (CMR) Substudy
Yousuf Razvi, Daniel P Judge, Ana Martinez-Naharro, et al.
Cardiovascular Drugs and Therapy
|
June 18, 2020
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)
Daniel P Judge, Arnt V Kristen, Martha Grogan, et al.
Nature Medicine
|
January 24, 2007
Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states
Ronald D Cohn, Christel van Erp, Jennifer P Habashi, et al.
Journal of Cardiovascular Development and Disease
|
January 29, 2016
Targeted <i>Mybpc3</i> Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities
Daniel P Judge, Hany Neamatalla, Russell A Norris, et al.
Journal of Personalized Medicine
|
August 26, 2022
Lessons Learned from the Pilot Phase of a Population-Wide Genomic Screening Program: Building the Base to Reach a Diverse Cohort of 100,000 Participants
Caitlin G Allen, Leslie Lenert, Kelly Hunt, et al.
Page
of 26